Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

C4 Therapeutics (CCCC) Return on Assets (2020 - 2025)

C4 Therapeutics' Return on Assets history spans 6 years, with the latest figure at 0.34% for Q4 2025.

  • For Q4 2025, Return on Assets fell 5.0% year-over-year to 0.34%; the TTM value through Dec 2025 reached 0.34%, down 5.0%, while the annual FY2025 figure was 0.3%, 1.0% down from the prior year.
  • Return on Assets reached 0.34% in Q4 2025 per CCCC's latest filing, up from 0.42% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.17% in Q4 2021 to a low of 0.42% in Q3 2025.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.29% recorded in 2022.
  • Peak YoY movement for Return on Assets: dropped -17bps in 2023, then grew 10bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.17% in 2021, then plummeted by -73bps to 0.29% in 2022, then plummeted by -31bps to 0.37% in 2023, then increased by 22bps to 0.29% in 2024, then decreased by -16bps to 0.34% in 2025.
  • Per Business Quant, the three most recent readings for CCCC's Return on Assets are 0.34% (Q4 2025), 0.42% (Q3 2025), and 0.36% (Q2 2025).